erlotinib has been researched along with cb-839 in 2 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (cb-839) | Trials (cb-839) | Recent Studies (post-2010) (cb-839) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 71 | 2 | 71 |
| Protein | Taxonomy | erlotinib (IC50) | cb-839 (IC50) |
|---|---|---|---|
| Glutaminase kidney isoform, mitochondrial | Mus musculus (house mouse) | 0.02 | |
| Glutaminase kidney isoform, mitochondrial | Homo sapiens (human) | 0.2025 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, J; Li, L; Li, Z; Meng, Y; Wang, J; Xu, P; Xu, X | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
2 other study(ies) available for erlotinib and cb-839
| Article | Year |
|---|---|
Overview of the Development of Glutaminase Inhibitors: Achievements and Future Directions.
Topics: Animals; Benzophenanthridines; Benzoquinones; Catalytic Domain; Cell Line, Tumor; Drug Discovery; Enzyme Inhibitors; Glutaminase; Humans; Mice; Molecular Docking Simulation; Protein Binding; Sulfides; Thiadiazoles; Thiazolidinediones | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |